Romero, 2005 - Google Patents

Characterization of the Plasmodium MB2 gene family and evaluation of animal model systems for studying MB2 function

Romero, 2005

Document ID
7805542341804291287
Author
Romero L
Publication year

External Links

Snippet

Malaria causes 300–500 million clinical cases and more than one million deaths worldwide each year. Efforts to reduce disease that rely on chemotherapeutics and insecticides are undermined by an increase in drug and insecticide resistance. The development of new …
Continue reading at search.proquest.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Similar Documents

Publication Publication Date Title
van Dijk et al. A central role for P48/45 in malaria parasite male gamete fertility
Galinski et al. Plasmodium vivax: who cares?
US7122179B2 (en) Live genetically attenuated malaria vaccine
Mikolajczak et al. Disruption of the Plasmodium falciparum liver‐stage antigen‐1 locus causes a differentiation defect in late liver‐stage parasites
Moitra et al. Expression, purification, and biological characterization of Babesia microti apical membrane antigen 1
Simwela et al. Current status of experimental models for the study of malaria
Mishra et al. Autophagy protein Atg7 is essential and druggable for maintaining malaria parasite cellular homeostasis and organelle biogenesis
Romero Characterization of the Plasmodium MB2 gene family and evaluation of animal model systems for studying MB2 function
Palmkvist Malaria and Polypeptides of Plasmodium falciparum at the Infected erythrocyte Surface
Kanai Investigating the determinants of resistance to quinine and chloroquine using a novel Plasmodium falciparum genetic cross
Mok Transcriptional variation in human malaria parasites and its association with drug resistance
Ukegbu Molecular analysis of Plasmodium genes regulating the gametocyte-to-ookinete-to-oocyst developmental transitions
Millar Gene knock-in as a tool to phenotype clinically relevant varient alleles for studies on malaria pathobiology: proof of concept using the plasmodium knowlesi normocyte binding protein Xa gene
Lim The RhopH1/Clag gene family in the human malaria parasite Plasmodium falciparum
NDUNG’U MOLECULAR MARKERS ASSOCIATED WITH AMODIAQUINE RESISTANCE IN RODENT MALARIA PARASITE Plasmodium berghei ANKA
Tucker Phenotypic and genotypic analysis of in vitro selected artemisinin resistant Plasmodium falciparum
Mello Characterization of proteins that interact with the amino-terminus of the plasmodium merozoite surface protein 1 (MSP-1)
JP6425304B2 (en) Protozoan proteins involved in the infection of malarial parasite liver stage
Cernetich Ott Global gene expression profiling, cytoadherence and immune evasion in Plasmodium yoelii blood-stage malaria parasites
Oteng et al. Discovery of a conserved Plasmodium antigen on the surface of malaria-infected red blood cells
Roberts Insights into understanding malaria parasite biology: characterization of the Plasmodium protein, MAL13P1. 319
Robinett Determining the Function of Plasmodium Hemolysin III and Discovery of Novel Antimalarial Drugs
Fox Regulation of TamS1 gene expression during differentiation to the merozoite in Theileria annulata
Pattaradilokrat Linkage Group Selection to Investigate Genetic Determinants of Complex Traits of Malaria Parasites
Lakshmanan Investigations into the genetic and biochemical basis of chloroquine resistance in malaria parasites